Federal Grants for Health



Department of Health and Human Services $62,853,680,968 Department of Transportation $56,443,571,981 Environmental Protection Agency $35,751,587,496 Department of Energy $24,661,368,000 National Aeronautics and Space Administration $14,032,768,821 Department of Homeland Security $13,986,266,741 Department of Labor $10,348,285,755 Department of Defense $10,111,366,675 Department of the Interior $9,806,569,960 Department of Agriculture $8,296,397,040 Agency for International Development $7,754,781,106 Department of Commerce $6,871,103,950 Department of Housing and Urban Development $6,642,477,476 Department of State $6,042,666,916 Department of Justice $5,571,395,802 Department of Education $2,642,831,221 Department of the Treasury $1,019,380,000 Other Agencies $724,036,487


Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional)

National Institutes of Health
This Notice of Funding Opportunity (NOFO) invites applications for a U54 Specialized Center to advance economic research on Alzheimers disease (AD) and AD-related dementias (ADRD) by supporting a...more
Posted On - 2023-08-28


Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional)

National Institutes of Health
This initiative will solicit research to target gaps in knowledge about barriers and facilitators to ring use, interventions to improve uptake, adherence, and persistence on the vaginal ring, and...more
Posted On - 2023-08-25


Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial Required)

National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to enhance NCIs program for conducting early phase clinical trials in children with cancer, thereby...more
Posted On - 2023-08-25




Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)

National Institutes of Health
This notice of funding opportunity (NOFO) promotes collaborative research programs to support the development/enhancement of infrastructure (e.g., tools, surveys, biospecimens, data) for...more
Posted On - 2023-08-25


Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

National Institutes of Health
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or...more
Posted On - 2023-08-24


Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

National Institutes of Health
The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, serum, and genomic DNA) and related research data on behaviors,...more
Posted On - 2023-08-24


Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional)

National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications from eligible organizations that can serve as Health Equity Research Hubs (Hubs) for awarded community-led health...more
Posted On - 2023-08-24

People Building Stronger Communities


Economic Status Affects Substance Abuse Among Youth

Hickman to Receive $25,000 in Tax Credits for New Community Center

Duluth to Host 9,000 Snow Angels for a Fundraiser

Celebrating Excellence in Community Finance

Debunking Common Homeless Youth Myths

MindMixer, Code for America Announces Ideation Nation Rally

Giving Back to the Environment \'All At Once\'

Federal Initiative Creates Reluctance from Philanthropic Donors

City Launches Mobile App for Civic Engagement

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

National Institutes of Health
The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or...more
Posted On - 2023-08-23


Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline...more
Posted On - 2023-08-23



<< Previous 9 Announcements
Next 9 Announcements >>


Social Entrepreneurship
Spotlight



Partnerships in Social Enterprises Can Increase Social Impact


Chief executive of HCT, Dai Powell, shares the experiences and practical lessons he learned along the way when teaming up with Ealing Community Transport to deliver site transport during the Olympic Park construction.


Grant Scams?

Learn How to Identify and Avoid Grant Scams




More Federal Domestic Assistance Programs


Fireboat Construction | Minerals and Mining on Indian Lands | Structural Fire Protection_Bureau of Indian Affairs Facilities | Grants-in-Aid for Railroad Safety_State Participation | Native Hawaiian Education |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders
© 2004-2024 Copyright Michael Saunders